Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000507153 | SCV000605511 | benign | not specified | 2017-03-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002323872 | SCV002629307 | likely benign | Cardiovascular phenotype | 2019-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002496972 | SCV002809176 | likely benign | Hyperthyroxinemia, dystransthyretinemic; Amyloidosis, hereditary systemic 1; Carpal tunnel syndrome 1 | 2022-01-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003766885 | SCV004621106 | likely benign | Amyloidosis, hereditary systemic 1 | 2023-11-01 | criteria provided, single submitter | clinical testing |